SharonAI Holdings, Inc Class A Common Stock (SHAZ) has had the highest return between July 19, 2023 and July 19, 2026 by a mid-cap US stock, returning 1,515,138.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
SharonAI Holdings, Inc Class A Common Stock (SHAZ) | 7/19/2023 - 7/19/2026 | 1,515,138.1% |
Dave (DAVE) | 7/19/2023 - 7/19/2026 | 7,489.52% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 7/19/2023 - 7/19/2026 | 3,880% |
Praxis Precision Medicines (PRAX) | 7/19/2023 - 7/19/2026 | 1,896.25% |
AXT (AXTI) | 7/19/2023 - 7/19/2026 | 1,454.58% |
Argan (AGX) | 7/19/2023 - 7/19/2026 | 1,346.95% |
Almonty Industries Inc Common Shares (ALM) | 7/19/2023 - 7/19/2026 | 1,260.13% |
Applied Opt (AAOI) | 7/19/2023 - 7/19/2026 | 1,221.42% |
Powell Industries (POWL) | 7/19/2023 - 7/19/2026 | 1,014.26% |
Belite Bio Inc ADR (BLTE) | 7/19/2023 - 7/19/2026 | 935.75% |
Liquidia Technologies (LQDA) | 7/19/2023 - 7/19/2026 | 926.19% |
Tutor Perini (TPC) | 7/19/2023 - 7/19/2026 | 890.15% |
Aura Minerals Inc Common Shares (AUGO) | 7/19/2023 - 7/19/2026 | 809.45% |
Definium Therapeutics (DFTX) | 7/19/2023 - 7/19/2026 | 803.88% |
Rush Street Interactive (RSI) | 7/19/2023 - 7/19/2026 | 802.78% |
Palvella Therapeutics (PVLA) | 7/19/2023 - 7/19/2026 | 797.49% |
Regencell Bioscience (RGC) | 7/19/2023 - 7/19/2026 | 787.71% |
Celcuity LLC (CELC) | 7/19/2023 - 7/19/2026 | 769.03% |
Trevi Therapeutics (TRVI) | 7/19/2023 - 7/19/2026 | 759.01% |
Tango Therapeutics (TNGX) | 7/19/2023 - 7/19/2026 | 732.65% |
Dianthus Therapeutics (DNTH) | 7/19/2023 - 7/19/2026 | 724.79% |
Nektar Therapeutics (NKTR) | 7/19/2023 - 7/19/2026 | 701.17% |
Sellas Life Sciences (SLS) | 7/19/2023 - 7/19/2026 | 671.35% |
Scholar Rock (SRRK) | 7/19/2023 - 7/19/2026 | 632.13% |
Erasca (ERAS) | 7/19/2023 - 7/19/2026 | 623.4% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.